首页> 外文期刊>Orthopedics >Stringent patient selection in bulk allograft reconstructions.
【24h】

Stringent patient selection in bulk allograft reconstructions.

机译:大量同种异体移植患者的严格选择。

获取原文
获取原文并翻译 | 示例
           

摘要

We hypothesized that stringent patient selection in the use of large bulk structural allografts for limb preservation would positively affect outcomes and decrease complication rates by eliminating certain comorbid or social factors known to contribute to the most detrimental sources of allograft failure: infection, fracture, and nonunion.Our selection criteria included patients who were younger than 50 years, nonsmokers, non-obese (body mass index <40), who did not receive radiation therapy to the recipient site perioperatively, and who underwent intercalary allograft reconstruction except in the upper extremity where osteoarticular allografts were permitted. Outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) and Toronto Extremity Salvage Score (TESS) scoring systems. Twenty-three patients fulfilled our cohort inclusion criteria. The overall survival rate for the 23 allografts was 91% (21/23). Average MSTS and TESS scores were 76% and 87%, respectively. Eleven of 23 patients experienced at least 1 complication requiring a second procedure. Musculoskeletal Tumor Society scores among patients experiencing no complications averaged 83% vs 71% for patients experiencing at least 1 complication. Average TESS scores were 89% and 86%, respectively.The results of our early experience indicate there is no appreciable difference in complication rates among our series of patients stringently selected for bulk allograft reconstruction compared to other previously reported studies.
机译:我们假设严格的患者选择使用大块结构同种异体移植物进行肢体保护将通过消除某些已知导致同种异体移植失败的最有害来源的合并症或社会因素,积极地影响结果并降低并发症发生率,包括感染,骨折和骨不连我们的选择标准包括年龄小于50岁,不吸烟,不肥胖(体重指数<40),围手术期未接受放射治疗的患者以及接受上肢同种异体移植重建的患者(上肢除外)。允许进行同种异体骨移植。使用肌肉骨骼肿瘤学会(MSTS)和多伦多肢体救助评分(TESS)评分系统评估结局。 23名患者符合我们的队列纳入标准。 23种同种异体移植物的总生存率为91%(21/23)。 MSTS和TESS的平均得分分别为76%和87%。 23名患者中有11名经历了至少1例并发症,需要进行第二次手术。在没有并发症的患者中,肌肉骨骼肿瘤学会的平均得分为83%,而在至少1种并发症中,得分为71%。 TESS的平均评分分别为89%和86%。我们早期经验的结果表明,与其他先前报道的研究相比,严格选择进行批量同种异体移植重建的一系列患者的并发症发生率没有明显的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号